Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489564 · ClinicalTrials.gov registry record
Mitochondrial Capacity in Pregnant Women
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT03489564: Completed study, sponsored by Pennington Biomedical Research Center.
NCT03489564 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03489564 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This Pilot \& Feasibility study will test the hypothesis that pregnant women who are more active will have better functioning mitochondria in vivo (higher ATPmax, via 31P-MRS), which will be positively related to maternal and infant mitochondrial function in vitro (higher oxygen consumption rates in primary myotubes and umbilical cord derived mesenchymal stem cells, respectively). Twenty pregnant women (10 active and 10 sedentary) will be recruited in the first trimester of pregnancy determined from self-reported physical activity and assessment by activity monitors. Placental biospecimens will be collected during delivery for other molecular mitochondrial analyses.
Primary Outcome
Infant in vitro mitochondrial capacity measured by oxygen consumption rates in umbilical cord derived mesenchymal stem cells at delivery
Interventions
- BEHAVIORAL Active
- BEHAVIORAL Sedentary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2020-02-11 |
What the finished NCT03489564 record still lists
NCT03489564 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Active is the first listed.
NCT03489564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03489564 about?
NCT03489564 is a clinical study titled "Mitochondrial Capacity in Pregnant Women". This Pilot \& Feasibility study will test the hypothesis that pregnant women who are more active will have better functioning mitochondria in vivo (higher ATPmax, via 31P-MRS), which will be positively related to maternal and infant mitochondrial function in vitro (higher oxygen consumption rates in...
What is the current status of trial NCT03489564?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-03-19. Estimated completion is 2020-02-11.
What interventions are being tested in trial NCT03489564?
The interventions under investigation include: Active (BEHAVIORAL), Sedentary (BEHAVIORAL).
Who is sponsoring clinical trial NCT03489564?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI